Editorial Standards

All LifeSpanSupply editorial content — blog articles, peptide glossary entries, head-to-head comparisons, quality pages, and category copy — is produced by our internal research editorial team. Writers are trained on peptide pharmacology literature (receptor biology, pharmacokinetics, published trial data) and write from primary sources rather than syndicated content farms.

We do not accept sponsored content, pay-for-placement product inclusions, or paid-link placements in editorial articles. Every product link on a blog article points to a SKU we stock; our editorial choices about which compounds to discuss are not driven by margin or inventory position.

Every factual claim about a peptide — mechanism of action, half-life, typical research-dose range, receptor target, published-trial evidence — is sourced from peer-reviewed primary literature or the official trial registries (ClinicalTrials.gov, EU Clinical Trials Register). We do not cite secondary summaries as primary evidence, and we do not source from pharmacy marketplaces or forum threads.

Where consensus is unclear or published data is limited (common in peptide research), we say so explicitly rather than manufacturing certainty. Animal-model results are labeled as animal-model results; human data ranges are labeled with their trial context.

All peptides sold by LifeSpanSupply are chemical reagents intended exclusively for in-vitro laboratory and research use. Editorial content frames compounds in research terms — dose ranges are "typical research doses" drawn from published protocols, mechanisms are described as the research literature describes them, and no article makes therapeutic-use claims. "For research use only" appears on every product, every COA, and every article disclaimer.

This framing is both a regulatory requirement under EU REACH / CLP and Asian research-reagent frameworks, and an honest reflection of what peptide research currently is: an active area of investigation where most compounds are still in the pre-clinical or early-clinical evidence window.

Each article passes through three review gates before publication:

1. Research review — every dose range, half-life, mechanism claim, and study citation is checked against the sources it claims to reference.
2. Compliance review — articles are checked for therapeutic-use claims, implicit human-dosing recommendations, or language that could be construed as medical advice. These are rewritten into research-use framing before publication.
3. Editorial review — final pass for clarity, internal consistency, and link integrity (every referenced product, glossary term, and comparison page resolves correctly).

Peptide research moves. Half-life estimates sharpen, receptor-affinity data gets published, and new trial results change the picture for specific compounds. When material new evidence emerges, we update the affected articles — not silently. Updated articles carry a visible "last updated" date, and substantive changes that overturn a previously-published claim are noted at the top of the article.

Factual errors that readers flag are corrected. If you find one, reach out through our contact form with the specific article and claim — we review every correction request and respond within a few business days.

We are building out a named-reviewer program for articles covering specific peptide classes. Named reviewers are credentialed researchers, clinicians, or peptide-chemistry specialists who agree to attach their name and credential to articles within their area of expertise.

Named-reviewer attribution is never fabricated and never retroactively added without the reviewer's consent. When an article has a named reviewer, the byline block at the top of the article will show their name, credential, and area of focus — linked to their reviewer profile. Articles without a named reviewer are attributed to the LifeSpanSupply Research Editorial Team collectively.

Researchers interested in joining the reviewer program: contact us through the form above with your credentials and area of expertise.

LifeSpanSupply is a research-reagent supplier. Editorial articles link to our product SKUs where a compound is mentioned and we stock it — this is commercial disclosure, not hidden advertising. Articles never promote a specific SKU or brand tier over another based on margin; the research recommendation and the commercial link are independent editorial decisions.

We do not accept paid guest posts. We do not accept backlink-exchange arrangements. We do not publish AI-generated content as editorial. Every article in our library is written and reviewed by the editorial team above.